Diabetes News

The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, manufacturer Abbott announced in a press release.

Among adults with diabetes who underwent PCI, rates of target lesion failure were similar for two drug-eluting stents, though net adverse clinical events varied between arms and differed for people taking insulin, data show.

A novel agent demonstrated a dose-dependent relationship with lectin-like oxidized LDL receptor-1 suppression, a mechanism to lower inflammatory and lipid risk, and was well tolerated in a small study of patients with type 2 diabetes.

Medicare Part B and Part D beneficiaries with diabetes who use insulin would have saved an average of $500 in 2020 if out-of-pocket insulin prices were capped at $35 that year, according to a report from HHS.

The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to delay the disease’s onset may be changing the conversation.

A few months ago, I would have questioned the value of universal screening for type 1 diabetes because we did not have anything to offer people who are at risk for the disease. However, we now have a drug — teplizumab-mzwv — that can delay the onset of type 1 diabetes. That is an important advance.

Cancer burden among older adults with type 2 diabetes has increased in the past 2 decades while all-cause mortality rates at all ages have decreased, according to a 20-year population-based study published in Diabetologia.

The FDA approved bexagliflozin, an oral SGLT2 inhibitor, to improve glycemic control for adults with type 2 diabetes, according to a company press release.

An 8-hour time-restricted eating intervention did not improve insulin sensitivity, insulin secretion or beta-cell function in a small group of adults with overweight or obesity, according to data from a randomized controlled trial.

GLP-1 receptor agonists may reduce the number of postprandial hypoglycemia episodes after bariatric surgery, but more research is needed to guide use in practice, according to a systematic review published in Obesity.